Table 2.
Fold change of the pooled protein glycopatterns in sera from patients with CHB or CHC, and healthy volunteers (HV) based upon ratio of the NFIs of each lectin.
Lectin | Specificity | Fold change(p value)a | ||
---|---|---|---|---|
CHB/HV | CHC/HV | CHC/CHB | ||
HHL | High-Mannose, Manα1-3Man, Manα1-6Man, Man5-GlcNAc2-Asn | 5.01(<0.001) | – | 0.21(<0.001) |
GSL-II | GlcNAc and agalactosylated tri/tetra antennary glycans | 2.35(0.04) | – | 0.24(0.008) |
EEL | Galα1-3(Fucα1-2)Gal (blood group B antigen) | 3.33(0.001) | – | – |
LTL | Fucα1-2Galβ1-4GlcNAc, Fucα1-3(Galβ1-4)GlcNAc, anti-H blood group specificity | 2.19(0.05) | 0.20(0.05) | 0.09(0.019) |
MPL | Galβ1-3GalNAc, GalNAc | 4.99(<0.001) | – | 0.26 (0.003) |
LEL | (GlcNAc)n, high mannose-type N-glycans | 5.62(0.034) | 5.02(0.058) | – |
GSL-I | αGalNAc, αGal, anti-A and B | 24.59(<0.001) | – | 0.07(0.007) |
DBA | αGalNAc, Tn antigen, GalNAcα1-3((Fucα1-2))Gal (blood group A antigen) | – | 0.47(0.004) | 0.26(<0.001) |
LCA | α-D-Man, Fucα-1,6GlcNAc, α-D-Glc | 0.39(0.002) | – | 3.93(0.002) |
PTL-II | Gal, blood group H, T-antigen | 9.67(<0.001) | – | 0.12(<0.001) |
SBA | α- or β-linked terminal GalNAc, (GalNAc)n, GalNAcα1-3Gal, blood-group A | 16.58(<0.001) | 3.15(0.040) | 0.19(0.0012) |
VVA | terminal GalNAc, GalNAcα-Ser/Thr(Tn), GalNAcα1-3Gal | 0.48(0.002) | – | – |
NPA | Galβ1-3GalNAcα-Ser/Thr(T-antigen) | 3.97(<0.001) | – | 0.14(<0.001) |
PSA | Fucoseα-1,6GlcNAc(core fucose) | 6.08(0.001) | – | 0.27(0.002) |
ACA | α-D-Man, Fucα-1,6GlcNAc, α-D-Glc | 0.28(0.002) | – | 3.08(0.002) |
WGA | Multivalent Sia and (GlcNAc)n | – | 2.32(0.013) | 2.00(0.05) |
UEA-I | Fucoseα1-2Galβ1-4Glc(NAc) | 14.32(<0.001) | – | 0.11(0.02) |
MAL-I | Galβ1-4GlcNAc, Siaα2-3Gal, Galβ1-3GlcNAc, Siaα2-3 | 3.39(0.001) | 2.97(0.005) | – |
SNA | Sia2-6Galβ1-4Glc(NAc) | – | – | 2.26(<0.001) |
The NFIs of each lectin from CHB and CHC groups were compared with that from HV group based on their fold change (i.e., CHB/HV and CHC/HV).
—, no significant difference.